Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Debruyne

Showing results (491-500 of 505) with videos related to

Pageof 51
Sort By:
Urology|March 1, 1988
BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trialF M DeBruyne, A P van der Meijden, A D Geboers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 1997
Conventional bladder wash cytology performed by four experts versus quantitative image analysisH G van der Poel, M E Boon, P van Stratum, et al.
The Prostate|April 30, 1999
High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective studyH P Beerlage, G J van Leenders, G O Oosterhof, et al.
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Cancer Research|April 10, 1999
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapyM G Steffens, O C Boerman, W J Oyen, et al.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Progress in Clinical and Biological Research|January 1, 1988
BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancerF M Debruyne, A P van der Meijden, L M Schreinemachers, et al.
In Vivo (Athens, Greece)|November 1, 1987
Multidisciplinary evaluation of rat renal cell carcinomaH F Karthaus, W F Feitz, A P vd Meijden, et al.
The Journal of Urology|August 1, 1989
Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinomaJ H Schornagel, J Verweij, W W ten Bokkel Huinink, et al.
European Urology|January 1, 1988
Intravesical and intradermal Bacillus Calmette-Guérin application. A phase I study to the toxicity of a Dutch Bacillus Calmette-Guérin preparation in patients with superficial bladder cancerL M Schreinemachers, A P van der Meijden, J Wagenaar, et al.
Pageof 51

Showing results (491-500 of 505) with videos related to

Sort By:
Pageof 51
Urology|March 1, 1988
BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trialF M DeBruyne, A P van der Meijden, A D Geboers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 5, 1997
Conventional bladder wash cytology performed by four experts versus quantitative image analysisH G van der Poel, M E Boon, P van Stratum, et al.
The Prostate|April 30, 1999
High-intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective studyH P Beerlage, G J van Leenders, G O Oosterhof, et al.
Urology|April 1, 1996
A dose-response study of the effect of flutamide on benign prostatic hyperplasia: results of a multicenter studyP Narayan, J Trachtenberg, H Lepor, et al.
Cancer Research|April 10, 1999
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapyM G Steffens, O C Boerman, W J Oyen, et al.
The Journal of Urology|May 1, 1987
Metastatic cancer of the prostate managed with buserelin versus buserelin plus cyproterone acetateF H Schroeder, T M Lock, D R Chadha, et al.
Progress in Clinical and Biological Research|January 1, 1988
BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancerF M Debruyne, A P van der Meijden, L M Schreinemachers, et al.
In Vivo (Athens, Greece)|November 1, 1987
Multidisciplinary evaluation of rat renal cell carcinomaH F Karthaus, W F Feitz, A P vd Meijden, et al.
The Journal of Urology|August 1, 1989
Phase II study of recombinant interferon alpha-2a and vinblastine in advanced renal cell carcinomaJ H Schornagel, J Verweij, W W ten Bokkel Huinink, et al.
European Urology|January 1, 1988
Intravesical and intradermal Bacillus Calmette-Guérin application. A phase I study to the toxicity of a Dutch Bacillus Calmette-Guérin preparation in patients with superficial bladder cancerL M Schreinemachers, A P van der Meijden, J Wagenaar, et al.
Pageof 51